Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36801 - 36825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CLDN11	5010	upregulated	entinostat results in increased expression of CLDN11 mRNA	3q26.2	A21035
Entinostat	Investigational	CLDN23	137075	upregulated	entinostat results in increased expression of CLDN23 mRNA	8p23.1	A21037
Entinostat	Investigational	CLDN6	9074	upregulated	entinostat results in increased expression of CLDN6 mRNA	16p13.3	A21037
Entinostat	Investigational	CLDN7	1366	upregulated	entinostat results in increased expression of CLDN7 mRNA	17p13.1	A21037
Entinostat	Investigational	CLEC11A	6320	upregulated	entinostat results in increased expression of CLEC11A mRNA	19q13.33	A21035
Entinostat	Investigational	CLEC12A	160364	upregulated	entinostat results in increased expression of CLEC12A mRNA	12p13.31	A21035
Entinostat	Investigational	CLEC18A	348174	downregulated	entinostat results in decreased expression of CLEC18A mRNA	16q22.1	A21037
Entinostat	Investigational	CLEC2B	9976	upregulated	entinostat results in increased expression of CLEC2B mRNA	12p13.31	A21035
Entinostat	Investigational	CLGN	1047	upregulated	entinostat results in increased expression of CLGN mRNA	4q31.1	A21035
Entinostat	Investigational	CLIC3	9022	upregulated	entinostat results in increased expression of CLIC3 mRNA	9q34.3	A21035
Entinostat	Investigational	CLIC4	25932	upregulated	entinostat results in increased expression of CLIC4 mRNA	1p36.11	A21037
Entinostat	Investigational	CLIC6	54102	upregulated	entinostat results in increased expression of CLIC6 mRNA	21q22.12	A21037 A21035
Entinostat	Investigational	CLIP4	79745	downregulated	entinostat results in decreased expression of CLIP4 mRNA	2p23.2	A21037
Entinostat	Investigational	CLMN	79789	upregulated	entinostat results in increased expression of CLMN mRNA	14q32.13	A21035
Entinostat	Investigational	CLPB	81570	upregulated	entinostat results in increased expression of CLPB mRNA	11q13.4	A21035
Entinostat	Investigational	CLRN3	119467	downregulated	entinostat results in decreased expression of CLRN3 mRNA	10q26.2	A21035
Entinostat	Investigational	CLU	1191	upregulated	entinostat results in increased expression of CLU mRNA	8p21.1	A21037 A21035
Entinostat	Investigational	CLUL1	27098	upregulated	entinostat results in increased expression of CLUL1 mRNA	18p11.32	A21035
Entinostat	Investigational	CMTM5	116173	upregulated	entinostat results in increased expression of CMTM5 mRNA	14q11.2	A21035
Entinostat	Investigational	CMTM8	152189	upregulated	entinostat results in increased expression of CMTM8 mRNA	3p22.3	A21035
Entinostat	Investigational	CNFN	84518	upregulated	entinostat results in increased expression of CNFN mRNA	19q13.2	A21035
Entinostat	Investigational	CNKSR2	22866	downregulated	entinostat results in decreased expression of CNKSR2 mRNA	Xp22.12	A21037
Entinostat	Investigational	CNMD	11061	upregulated	entinostat results in increased expression of CNMD mRNA	13q14.3	A21037
Entinostat	Investigational	CNN1	1264	upregulated	entinostat results in increased expression of CNN1 mRNA	19p13.2	A21035
Entinostat	Investigational	CNOT3	4849	downregulated	entinostat results in decreased expression of CNOT3 mRNA	19q13.42	A21037

Displaying entries 36801 - 36825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability